Primary colorectal choriocarcinoma is a rare neoplasm. Only 19 cases have been reported worldwide, most of which involved adenocarcinomas. The prognosis is usually poor, and the standard therapy for this tumor has not been established. A 61-year-old woman presented with constipation and lower abdominal discomfort. She was diagnosed with primary adenocarcinoma with focal choriocarcinomatous differentiation in the sigmoid colon and liver metastasis. Because the serum beta-human chorionic gonadotropin level was not significantly elevated, and because only focal choriocarcinomatous differentiation was diagnosed, we selected the chemotherapy regimen that is used for the treatment of metastatic colorectal adenocarcinoma. The patient survived for 13 months after the initial diagnosis. This is the first case in Korea to assess the suppressive effects of the standard chemotherapy for colorectal adenocarcinoma against coexisting colorectal choriocarcinoma and adenocarcinoma. (Korean J Gastroenterol 2015;66:291-296) 
INTRODUCTION
Choriocarcinoma is a malignant form of trophoblastic cancer that arises in the placenta. It can be subclassified as a gestational or non-gestational tumors. Gestational tumors arise in the testis or ovary, whereas non-gestational, extra-gonadal choriocarcinomas are rare tumors that can develop in the mediastinum, lung, stomach, pancreas, cervix, ureter, or colon. Primary colorectal choriocarcinoma is an even rarer tumor; only 16 cases have been published in the English medical literature, and only three cases have been reported in Korea. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] Most of these tumors were associated with adenocarcinoma. We report a case involving a 61-year-old woman diagnosed with primary adenocarcinoma with focal choriocarcinomatous differentiation in the sigmoid colon.
Based on this case, we also examine the clinical features, pathogenesis, and treatment of colorectal choriocarcinoma through a review of the literature.
CASE REPORT
A 61-year-old woman presented with a one month history of constipation and lower abdominal discomfort. Her medical history included hypertension. Colonoscopy showed se- vere stenosis and an ulcerative mass encircling the sigmoid colon ( Fig. 1) . Abdominal CT revealed an ulcero-infiltrating mass in the sigmoid colon and liver metastasis ( Fig. 2A, B) .
Histologically, the tumor had two components: moderately differentiated adenocarcinoma, and syncytiotrophoblast-like tumor cells with highly pleomorphic, bizarre nuclei and abundant eosinophilic cytoplasm (Fig. 3A) . The two components were either intimately admixed or separate from each other (Fig. 3B) . The latter component showed positive immunohistochemical staining for beta-human chorionic gonadotropin (beta-hCG), a marker of choriocarcinoma (Fig. 3C ).
Accordingly, a diagnosis of moderately differentiated adenocarcinoma with focal choriocarcinomatous differentiation was made.
The CEA and CA 19-9 levels were markedly elevated at Abdominal CT showed an interval increase with a mass at the sigmoid colon and liver metastasis (Fig. 2E, F) . The CEA and CA 19-9 levels were elevated to 730.5 ng/mL and 3,675.4 U/mL, respectively, and the beta-hCG level were at 5.5 mIU/mL. These findings were indicative of progressive disease according to the Response Evaluation Criteria in Solid
Tumors. Thereafter, we inserted a second SEMS (8 cm, uncovered; M.I.Tech), and changed the chemotherapy regimen to leucovorin, fluorouracil, and oxaliplatin (FOLFOX) on days 1-2, administered every two weeks. However, despite three courses of treatment with this chemotherapy regimen, the symptoms persisted. Abdominal CT revealed that an abscess had developed in the sigmoid colon. We therefore administered antibiotics and performed percutaneous drainage by inserting a 10.2-F pigtail catheter, followed by supportive care. However, 13 months after the initial diagnosis, the patient died of liver failure due to the hepatic metastasis.
DISCUSSION
Choriocarcinoma progresses rapidly and is associated with a poor prognosis. These features are thought to result from the tumor's derivation from chorionic tissue, which normally invades and destroys the adjacent tissue, and this behavior persists after malignant transformation. For this reason, hematogenous and lymphatic metastasis is common at the time of the initial diagnosis. 8 The stomach is the most common site of choriocarcinoma in the gastrointestinal tract, and primary choriocarcinoma of the colon is extremely rare.
16
Only 20 cases of colorectal choriocarcinoma (including the case described here) have been reported worldwide (Table   1) . [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] In the literature, primary colorectal choriocarcinoma was associated with adenocarcinoma in all except four cases, 6, 12, 15, 17 in which only choriocarcinoma was noted and was accompanied by metastatic tumors at the time of diagnosis in 16 of 20 cases (80%). The median survival period was eight months (range, 0.5-60 months).
The most reasonable pathogenesis of primary choriocarcinoma is dedifferentiation or retrodifferentiation of a carcinoma. This hypothesis is based on the premise that an adenocarcinoma can dedifferentiate into a choriocarcinoma, both functionally and morphologically.
Verbeek et al. 13 reported a genetic evolution model, which
showed that genes located on the X chromosome may be involved in the phenotypic switch from adenocarcinoma to choriocarcinomatous differentiation.
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The Korean Journal of Gastroenterology Gestational choriocarcinoma is sensitive to chemotherapy if therapy is initiated within three months. 18 The preferred regimen for the treatment of gestational choriocarcinoma was etoposide, methotrexate, and actinomycin D, alternating with cyclophosphamide and vincristine (EMA/CO).
However, a standard treatment for primary colorectal choriocarcinoma has not been established. Additionally, the response of colorectal choriocarcinomas to chemotherapy is 
